StatPearls

StatPearls

Book. 2018 01

Authors:

Abstract
Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and children over the age of 6. Although atomoxetine is only FDA approved for the treatment of ADHD, it is sometimes used off-label for treatment of adult patients with treatment-resistant depression. It is sold under the brand name Strattera and is also available as a generic.

PMID: 29630286

via https://www.ncbi.nlm.nih.gov/pubmed/29630286?dopt=Abstract